Bloomberg Businessweek
Teva CEO on Staying Competitive in Generic Drug Market
14 min•13 februari 2020
Om avsnittet
Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva.
Host: Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
Fler avsnitt
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.